G16B 40/20
Supervised data analysis
G16B40/20 (Supervised data analysis) appears on 1,339 US grants and 4,221 published applications in this corpus.
Search patents in G16B- Granted patents
- 1,339
- Published applications
- 4,221
- Assignees
- 1,474
- Inventors
- 8,744
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 1 |
| 2002 | 3 | 22 |
| 2003 | 3 | 36 |
| 2004 | 5 | 32 |
| 2005 | 7 | 37 |
| 2006 | 12 | 29 |
| 2007 | 7 | 40 |
| 2008 | 10 | 32 |
| 2009 | 11 | 25 |
| 2010 | 23 | 38 |
| 2011 | 20 | 49 |
| 2012 | 21 | 37 |
| 2013 | 13 | 58 |
| 2014 | 29 | 51 |
| 2015 | 28 | 51 |
| 2016 | 19 | 80 |
| 2017 | 27 | 119 |
| 2018 | 38 | 150 |
| 2019 | 96 | 231 |
| 2020 | 90 | 272 |
| 2021 | 82 | 272 |
| 2022 | 159 | 423 |
| 2023 | 150 | 522 |
| 2024 | 157 | 521 |
| 2025 | 174 | 600 |
| 2026 | 147 | 493 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- System and method for determining an immune activation state6 Oct 2026US 12,752,274 B2CytoVale Inc.
- Analyte characterization via iterative analysis6 Oct 2026US 12,754,188 B2Nautilus Subsidiary, Inc.
- Optimization of genetic sequences6 Oct 2026US 12,755,812 B1Nanil Therapeutics Inc.
- Platforms, systems, and methods for rapid fermenter sampling6 Oct 2026US 12,755,814 B2X Development LLC
- Methods for selecting and treating cancer with FGFR3 inhibitors29 Sep 2026US 12,748,103 B2GeneCentric Therapeutics, Inc.
- Electrochemical biosensors, systems, and methods of use8 Oct 2026US 2026/0309671 A1
- Early detection and monitoring of neurodegenerative diseases using a multidisease diagnostic platform8 Oct 2026US 2026/0309723 A1Durin Life Sciences, Inc.
- Systems and methods for karyotyping by sequencing8 Oct 2026US 2026/0311332 A1CytoTerra Inc.
- Clearance prediction according to antibody property analysis8 Oct 2026US 2026/0311799 A1
- System and method for determining candidate rna binders8 Oct 2026US 2026/0311801 A1Ladder Therapeutics, Inc.
Most cited
By later US patents
- Prediction of prostate cancer progression by analysis of selected predictive parameters195US 6,025,128 ACytodiagnostics, Inc. · 2000
- Methods, systems, and software for identifying functional biomolecules193US 7,783,428 B2Maxygen, Inc. · 2010
- Method for analyzing mass spectra173US 6,675,104 B2Ciphergen Biosystems, Inc. · 2004
- Method for monitoring molecular species within a medium171US 7,097,973 B1Alpha M.O.S. · 2006
- Methods, systems, and software for identifying functional biomolecules171US 7,747,391 B2Maxygen, Inc. · 2010